by In2Pharma | Dec 2, 2024 | News
Europe As part of Regulation (EU) 2022/123, an EU platform has been realised to prevent, monitor, and manage any medicine shortages across the EU of centrally authorised medicines. The European Shortages Monitoring Platform (ESMP) has the purpose to facilitate...
by In2Pharma | Nov 5, 2024 | News
Belgium The Royal Decree published on 30 September 2024, amending the Royal Decree of 14 December 2006 on medicinal products for human and veterinary use, adds two elements concerning the search for substitutes, in the event of unavailability. In the first place, a...
by In2Pharma | Nov 5, 2024 | News
Belgium Starting January 1st, 2025, new legislation will come into force that requires the pharmaceutical industry to compensate for the additional costs caused by the unavailability of essential reimbursable medicines. This law aims to ensure patients still have...
by In2Pharma | Dec 6, 2023 | News
Europe To prevent and mitigate shortages of critical medicines in the European Union, the EU commission has adopted a couple measures. These measures aim at ensuring adequate supply of medicines or managing medicine shortages. Examples of planned measures are:...
by In2Pharma | Feb 16, 2022 | News
The Netherlands Medicinal Product Quality Defects and Shortages on the Dutch Market should be reported through the “Meldpunt geneesmiddelentekorten en -defecten”. As of 01 January 2022, the Medicines Evaluation Board (MEB) and the Inspectorate (IGJ) have implemented...